Robert E. Ward
2019 - Sevion Therapeutics
In 2019, Robert E. Ward earned a total compensation of $2.5M as Chief Executive Officer at Sevion Therapeutics, a 179% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $200,000 |
|---|---|
| Option Awards | $1,771,840 |
| Salary | $500,000 |
| Other | $47,408 |
| Total | $2,519,248 |
Ward received $1.8M in option awards, accounting for 70% of the total pay in 2019.
Ward also received $200K in non-equity incentive plan, $500K in salary and $47.4K in other compensation.
Rankings
In 2019, Robert E. Ward's compensation ranked 4,824th out of 13,971 executives tracked by ExecPay. In other words, Ward earned more than 65.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,824 out of 13,971 | 66th |
Division Manufacturing | 1,799 out of 5,701 | 68th |
Major group Chemicals And Allied Products | 625 out of 2,200 | 72nd |
Industry group Drugs | 526 out of 1,886 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 117 out of 389 | 70th |
Source: SEC filing on April 1, 2020.
Ward's colleagues
We found three more compensation records of executives who worked with Robert E. Ward at Sevion Therapeutics in 2019.